Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Affymax Inc (AFFY)

Affymax Inc (AFFY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 0
  • Shares Outstanding, K 0
  • Annual Sales, $ 1,370 K
  • Annual Income, $ -14,420 K
  • 60-Month Beta 5.90
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AFFY with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 10/01/15
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0007 unch
on 04/23/24
0.0021 -66.67%
on 04/22/24
unch (unch)
since 03/13/24
3-Month
0.0007 unch
on 04/23/24
0.0021 -66.67%
on 04/22/24
-0.0014 (-66.67%)
since 01/19/24
52-Week
0.0002 +250.00%
on 10/13/23
0.0400 -98.25%
on 07/26/23
-0.0194 (-96.52%)
since 04/21/23

Most Recent Stories

More News
Pipeline Therapeutics Appoints Julie Iwashita as Vice President of Clinical Operations

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, today announced the appointment of Julie Iwashita...

KOD : 3.38 (+1.50%)
AFFY : 0.0007 (-66.67%)

Business Summary

AFFYMAX INC., is a biopharmaceutical company that is developing a pipeline of synthetic peptide-based drug candidates against clinically validated targets for the treatment of kidney diseases and cancer. Affymax's objective is to discover, develop and commercialize novel therapeutics addressing large...

See More

Key Turning Points

3rd Resistance Point 0.0007
2nd Resistance Point 0.0007
1st Resistance Point 0.0007
Last Price 0.0007
1st Support Level 0.0007
2nd Support Level 0.0007
3rd Support Level 0.0007

See More

52-Week High 0.0400
Fibonacci 61.8% 0.0248
Fibonacci 50% 0.0201
Fibonacci 38.2% 0.0154
Last Price 0.0007
52-Week Low 0.0002

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar